iiinova — where your digital self keeps evolving

EVITA Trial

@evita-trial.bsky.social

EVITA is a UK multicentre randomised controlled trial comparing intravenous magnesium sulfate, aminophylline and salbutamol in 2–18-year-olds with severe acute asthma unresponsive to inhaled therapy.

Posts Replies Media

EVITA Trial @evita-trial.bsky.social · 01/10/2026

September has been a record month with a total of 70 participants randomised! 🗺️Opened to recruitment: University Hospitals Birmingham NHS Foundation Trust and King's College Hospital NHS Foundation Trust 🎖️Highest recruiting site: Royal Free London NHS Foundation Trust

000

EVITA Trial @evita-trial.bsky.social · 26/08/2026

Today our August newsletter was shared. August has been a quieter month overall, but this was expected given the seasonal variation in asthma. 🗺️Opened to recruitment this month: Portsmouth Hospitals University NHS Trust 🎖️Highest recruiting site: Leeds Teaching Hospital NHS Trust

000

EVITA Trial @evita-trial.bsky.social · 24/07/2026

Today our first monthly newsletter was shared. 🗺️First recruitment: Birmingham Children's Hospital & Royal Devon and Exeter Hospital 🎖️Highest recruiting sites: University Hospital of Wales and St Mary's Hospital, London

000

EVITA Trial @evita-trial.bsky.social · 24/07/2026

Welcome to the official page for the EVITA Trial. EVITA is a UK multicentre randomised controlled trial comparing intravenous magnesium sulfate, aminophylline and salbutamol in 2–18-year-olds with severe acute asthma unresponsive to inhaled therapy. We’ll be sharing updates on the study’s progress.

010